Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
CNSL Stock Chart & Stats
2.25p
-0.05p(-1.67%)
At close: 4:00 PM EST
2.25p
-0.05p(-1.67%)
Day’s Range― - ―
52-Week Range1.86p - 4.38p
Previous CloseN/A
Volume6.91K
Average Volume (3M)353.57K
Market Cap
£5.35M
Enterprise Value3.91M
Total Cash (Recent Filing)£4.87M
Total Debt (Recent Filing)£349.00K
Price to Earnings (P/E)3.9
Beta1.07
Next Earnings
Jul 29, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding237,950,650
10 Day Avg. Volume111,535
30 Day Avg. Volume353,573
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.64
Price to Sales (P/S)0.87
P/FCF Ratio-51.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Omega Diagnostics News
CNSL FAQ
What was Omega Diagnostics Group PLC’s price range in the past 12 months?
Omega Diagnostics Group PLC lowest share price was 1.85p and its highest was 4.38p in the past 12 months.
What is Omega Diagnostics Group PLC’s market cap?
Omega Diagnostics Group PLC’s market cap is £5.35M.
When is Omega Diagnostics Group PLC’s upcoming earnings report date?
Omega Diagnostics Group PLC’s upcoming earnings report date is Jul 29, 2026 which is in 242 days.
How were Omega Diagnostics Group PLC’s earnings last quarter?
Omega Diagnostics Group PLC released its earnings results on Nov 10, 2025. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
Is Omega Diagnostics Group PLC overvalued?
According to Wall Street analysts Omega Diagnostics Group PLC’s price is currently Overvalued.
Does Omega Diagnostics Group PLC pay dividends?
Omega Diagnostics Group PLC does not currently pay dividends.
What is Omega Diagnostics Group PLC’s EPS estimate?
Omega Diagnostics Group PLC’s EPS estimate is >-0.01.
How many shares outstanding does Omega Diagnostics Group PLC have?
Omega Diagnostics Group PLC has 237,950,650 shares outstanding.
What happened to Omega Diagnostics Group PLC’s price movement after its last earnings report?
Omega Diagnostics Group PLC reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -15.094%.
Which hedge fund is a major shareholder of Omega Diagnostics Group PLC?
Currently, no hedge funds are holding shares in GB:CNSL
Company Description
Omega Diagnostics Group PLC
Omega Diagnostics (CNSL) is a biotechnology company focused on the development and commercialization of diagnostic tests for various medical conditions, particularly in the areas of allergy and infectious disease. The company operates primarily in the healthcare sector, leveraging its expertise in immunoassay technology to deliver high-quality, reliable diagnostic solutions. Core products include a range of diagnostic kits that are used by healthcare professionals to improve patient outcomes through accurate and timely testing.
Technical Analysis
RUA Life Sciences
―
EKF Diagnostics Holdings
―
Feedback
―
Cizzle Biotechnology Holdings PLC
―
Tristel
―
Options Prices
Currently, No data available
---